288 related articles for article (PubMed ID: 25195922)
21. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
22. Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs.
Heiniö C; Sorsa S; Siurala M; Grönberg-Vähä-Koskela S; Havunen R; Haavisto E; Koski A; Hemminki O; Zafar S; Cervera-Carrascon V; Munaro E; Kanerva A; Hemminki A
Hum Gene Ther; 2019 Jun; 30(6):740-752. PubMed ID: 30672366
[TBL] [Abstract][Full Text] [Related]
23. Advanced targeting strategies for murine retroviral and adeno-associated viral vectors.
Yu JH; Schaffer DV
Adv Biochem Eng Biotechnol; 2005; 99():147-67. PubMed ID: 16568891
[TBL] [Abstract][Full Text] [Related]
24. Design of virus-based nanomaterials for medicine, biotechnology, and energy.
Wen AM; Steinmetz NF
Chem Soc Rev; 2016 Jul; 45(15):4074-126. PubMed ID: 27152673
[TBL] [Abstract][Full Text] [Related]
25. Synthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.
Cable J; Leonard JN; Lu TK; Xie Z; Chang MW; Fernández LÁ; Lora JM; Kaufman HL; Quintana FJ; Geiger R; F Lesser C; Lynch JP; Hava DL; Cornish VW; Lee GK; DiAndreth B; Fero M; Srivastava R; De Coster T; Roybal KT; Rackham OJL; Kiani S; Zhu I; Hernandez-Lopez RA; Guo T; Chen WCW
Ann N Y Acad Sci; 2021 Dec; 1506(1):98-117. PubMed ID: 34786712
[TBL] [Abstract][Full Text] [Related]
26. Methods of gene delivery.
Wivel NA; Wilson JM
Hematol Oncol Clin North Am; 1998 Jun; 12(3):483-501. PubMed ID: 9684094
[TBL] [Abstract][Full Text] [Related]
27. Biological gene delivery vehicles: beyond viral vectors.
Seow Y; Wood MJ
Mol Ther; 2009 May; 17(5):767-77. PubMed ID: 19277019
[TBL] [Abstract][Full Text] [Related]
28. Plant Viruses: From Targets to Tools for CRISPR.
Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
[TBL] [Abstract][Full Text] [Related]
29. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
Walther W; Stein U
Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
[TBL] [Abstract][Full Text] [Related]
30. Modular and Integrative Vectors for Synthetic Biology Applications in
Aubry C; Pernodet JL; Lautru S
Appl Environ Microbiol; 2019 Aug; 85(16):. PubMed ID: 31175189
[TBL] [Abstract][Full Text] [Related]
31. A versatile plasmid architecture for mammalian synthetic biology (VAMSyB).
Haellman V; Strittmatter T; Bertschi A; Stücheli P; Fussenegger M
Metab Eng; 2021 Jul; 66():41-50. PubMed ID: 33857582
[TBL] [Abstract][Full Text] [Related]
32. Harnessed viruses in the age of metagenomics and synthetic biology: an update on infectious clone assembly and biotechnologies of plant viruses.
Pasin F; Menzel W; Daròs JA
Plant Biotechnol J; 2019 Jun; 17(6):1010-1026. PubMed ID: 30677208
[TBL] [Abstract][Full Text] [Related]
33. We still have a long way to go to effectively deliver genes!
Pezzoli D; Chiesa R; De Nardo L; Candiani G
J Appl Biomater Funct Mater; 2012 Sep; 10(2):82-91. PubMed ID: 23015375
[TBL] [Abstract][Full Text] [Related]
34. Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery.
Ajithkumar KC; Pramod K
Mini Rev Med Chem; 2018; 18(3):276-286. PubMed ID: 28552048
[TBL] [Abstract][Full Text] [Related]
35. Engineering and control of biological systems: A new way to tackle complex diseases.
Menolascina F; Siciliano V; di Bernardo D
FEBS Lett; 2012 Jul; 586(15):2122-8. PubMed ID: 22580058
[TBL] [Abstract][Full Text] [Related]
36. Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors.
Liu J; Koay TW; Maiakovska O; Zayas M; Grimm D
Hum Gene Ther; 2023 May; 34(9-10):350-364. PubMed ID: 37082964
[TBL] [Abstract][Full Text] [Related]
37. Synthetic immunosurveillance systems: nanodevices to monitor physiological events.
Woappi YL; Jangiti R; Singh OV
Biosens Bioelectron; 2014 Nov; 61():152-64. PubMed ID: 24874659
[TBL] [Abstract][Full Text] [Related]
38. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
Jönsson F; Hagedorn C; Kreppel F
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
[TBL] [Abstract][Full Text] [Related]
39. Programming gene and engineered-cell therapies with synthetic biology.
Kitada T; DiAndreth B; Teague B; Weiss R
Science; 2018 Feb; 359(6376):. PubMed ID: 29439214
[TBL] [Abstract][Full Text] [Related]
40. Tunable protease-activatable virus nanonodes.
Judd J; Ho ML; Tiwari A; Gomez EJ; Dempsey C; Van Vliet K; Igoshin OA; Silberg JJ; Agbandje-McKenna M; Suh J
ACS Nano; 2014 May; 8(5):4740-6. PubMed ID: 24796495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
